NCT00003450View on ClinicalTrials.gov

Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Primary Completion Date

January 31, 1999

Study Completion Date

January 31, 1999

Conditions
Ovarian CancerPeritoneal Cavity Cancer
Interventions
BIOLOGICAL

Ad5CMV-p53 gene

Trial Locations (1)

75235-9154

Simmons Cancer Center - Dallas, Dallas

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT00003450 - Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter